Umbelliferone Ameliorates Hepatic Steatosis and Lipid-Induced ER Stress in High-Fat Diet-Induced Obese Mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Among the characteristics of non-alcoholic fatty liver disease (NAFLD), hepatic steatosis is due to excessive fat accumula tion and causes liver damage and lipotoxicity, which are associated with insulin resistance, endoplasmic reticulum (ER) stress, and apoptosis. Umbelliferone (UMB) has various powerful pharmacological properties, such as antioxidant, anti-hyperglycemic, anti-viral, and anti-inflammatory effects. However, the mechanism of action in hepatic steatosis and lipid-induced ER stress is still unclear. Thus, the efficacy of UMB in hepatic steatosis and palmitate (PA)-induced hepatocellular lipotoxicity was evaluated in the present study. Materials and Methods: Male C57BL/6J mice (n=40) were divided into four groups: regular diet (RD), UMB-supplemented RD, high-fat diet (HFD), and UMB-supplemented HFD. All mice were fed orally for 12 weeks. In addition, the effects of UMB on lipo toxicity were investigated in AML12 cells treated with PA (250 μM) for 24 h; Western blot analysis was used to evaluate the chang es in ER stress and apoptotic-associated proteins. Results: Administration with UMB in HFD-fed mice reduced lipid accumulation and hepatic triglyceride (TG) as well as serum insulin and glucose levels. In AML12 cells, UMB treatment reduced lipid accumulation as indicated by decreases in the levels of lipogenesis markers, such as SREBP1, FAS, PPAR-γ, and ADRP. Furthermore, UMB reduced both oxidative stress and ER stress-re lated cellular apoptosis. Conclusion: UMB supplementation ameliorated hepatic steatosis and improved insulin resistance by inhibiting lipid accumula tion and regulating ER stress. These findings strongly suggest that UMB may be a potential therapeutic compound against NAFLD.
Abstract
Purpose: Among the characteristics of non-alcoholic fatty liver disease (NAFLD), hepatic steatosis is due to excessive fat accumula tion and causes liver damage and lipotoxicity, which are associated with insulin resistance, endoplasmic reticulum (ER) stress, and apoptosis. Umbelliferone (UMB) has various powerful pharmacological properties, such as antioxidant, anti-hyperglycemic, anti-viral, and anti-inflammatory effects. However, the mechanism of action in hepatic steatosis and lipid-induced ER stress is still unclear. Thus, the efficacy of UMB in hepatic steatosis and palmitate (PA)-induced hepatocellular lipotoxicity was evaluated in the present study. Materials and Methods: Male C57BL/6J mice (n=40) were divided into four groups: regular diet (RD), UMB-supplemented RD, high-fat diet (HFD), and UMB-supplemented HFD. All mice were fed orally for 12 weeks. In addition, the effects of UMB on lipo toxicity were investigated in AML12 cells treated with PA (250 μM) for 24 h; Western blot analysis was used to evaluate the chang es in ER stress and apoptotic-associated proteins. Results: Administration with UMB in HFD-fed mice reduced lipid accumulation and hepatic triglyceride (TG) as well as serum insulin and glucose levels. In AML12 cells, UMB treatment reduced lipid accumulation as indicated by decreases in the levels of lipogenesis markers, such as SREBP1, FAS, PPAR-γ, and ADRP. Furthermore, UMB reduced both oxidative stress and ER stress-re lated cellular apoptosis. Conclusion: UMB supplementation ameliorated hepatic steatosis and improved insulin resistance by inhibiting lipid accumula tion and regulating ER stress. These findings strongly suggest that UMB may be a potential therapeutic compound against NAFLD.
참고문헌 (40)
- Eslam M, "Genetics and epigenetics of NAFLD and NASH : clinical impact", J Hepatol, 68, pp.268~279 (2018)
- Marchesini G, "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", Hepatology, 37, pp.917~923 (2003)
- Kumar S, "Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis", Adv Drug Deliv Rev, 176, pp.113869~ (2021)
- Khan RS, "Modulation of insulin resistance in nonalcoholic fatty liver disease", Hepatology, 70, pp.711~724 (2019)
- Ioannou GN, "The role of cholesterol in the pathogenesis of NASH", Trends Endocrinol Metab, 27, pp.84~95 (2016)
- Rada P, "Understanding lipotoxicity in NAFLD pathogenesis : is CD36 a key driver?", Cell Death Dis, 11, pp.802~ (2020)
- Wang D, "Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis", Endocrinology, 147, pp.943~951 (2006)
- Adams CJ, "Structure and molecular mechanism of ER stress signaling by the unfolded protein response signal activator IRE1", Front Mol Biosci, 6, pp.11~ (2019)
- Rutkowski DT, "Liver function and dysfunction-a unique window into the physiological reach of ER stress and the unfolded protein response", FEBS J, 286, pp.356~378 (2019)
- Jiao P, "FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKβ pathways", Obesity(Silver Spring), 19, pp.483~491 (2011)
- Kawasaki N, "Obesityinduced endoplasmic reticulum stress causes chronic inflammation in adipose tissue", Sci Rep, 2, pp.799~ (2012)
- Chen Z, "Curcumin protects against palmitic acid-induced apoptosis via the inhibition of endoplasmic reticulum stress in testicular Leydig cells", Reprod Biol Endocrinol, 17, pp.71~ (2019)
- Kim DS, "Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells", Immunopharmacol Immunotoxicol, 32, pp.251~257 (2010)
- Hoult JR, "Pharmacological and biochemical actions of simple coumarins : natural products with therapeutic potential", Gen Pharmacol, 27, pp.713~722 (1996)
- Wang HQ, "Umbelliferone ameliorates renal function in diabetic nephropathy rats through regulating inflammation and TLR", NF-κB pathway, 2019, pp.17, 346~354
- Mahmoud AM, "Umbelliferone ameliorates CCl4-induced liver fibrosis in rats by upregulating PPARγ and attenuating oxidative stress, inflammation, and TGF-β1", Smad3 signaling, 2019, pp.42, 1103~1116
- Yin J, "Umbelliferone alleviates hepatic injury in diabetic db", db mice via inhibiting inflammatory response and activating Nrf2-mediated antioxidant, 2018, pp.38, BSR20180444~
- Lee ES, "Curcumin analog CUR5-8 ameliorates nonalcoholic fatty liver disease in mice with high-fat diet-induced obesity", Metabolism, 103, pp.154015~ (2020)
- Ramesh B, "Antioxidant role of umbelliferone in STZ-diabetic rats", Life Sci, 79, pp.306~310 (2006)
- Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)
- Tilg H, "Insulin resistance, inflammation, and non-alcoholic fatty liver disease", Trends Endocrinol Metab, 19, pp.371~379 (2008)
- Jensen-Urstad AP, "Fatty acid synthase and liver triglyceride metabolism : housekeeper or messenger?", Biochim Biophys Acta, 1821, pp.747~753 (2012)
- Lattuada G, "Why does NAFLD predict type 2 diabetes?", Curr Diab Rep, 11, pp.167~172 (2011)
- Fracanzani AL, "Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels : a role for insulin resistance and diabetes", Hepatology, 48, pp.792~798 (2008)
- Speakman JR, "Use of high-fat diets to study rodent obesity as a model of human obesity", Int J Obes(Lond), 43, pp.1491~1492 (2019)
- Li J, "High fat diet induced obesity model using four strainsof mice : Kunming, C57BL", 6, BALB, Exp Anim, pp.2020, 69[DOI]
- Recena Aydos L, "Nonalcoholic fatty liver disease induced by high-fat diet in C57bl", 6models, 2019, pp.11, 3067~
- Trefts E, "The liver", Curr Biol, 27, pp.R1147~R1151 (2017)
- Cusi K, "Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis : pathophysiology and clinical implications", Gastroenterology, 142, pp.711~725 (2012)
- Kanda T, "Apoptosis and non-alcoholic fatty liver diseases", World J Gastroenterol, 24, pp.2661~2672 (2018)
- Scheuner D, "The unfolded protein response : a pathway that links insulin demand with beta-cell failure and diabetes", Endocr Rev, 29, pp.317~333 (2008)
- Pagliassotti MJ, "Endoplasmic reticulum stress in nonalcoholic fatty liver disease", Annu Rev Nutr, 32, pp.17~33 (2012)
- Liu J, "Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis", J Gastroenterol Hepatol, 25, pp.613~618 (2010)
- Xu S, "Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress", Cell Death Dis, 6, pp.e1976~ (2015)
- Rozpedek W, "The role of the PERK", eIF2α, CHOP signaling pathway in tumor progression during endoplasmic reticulum stress, pp.Curr Mol Med, 2016[DOI]
- Czabotar PE, "Control of apoptosis by the BCL-2 protein family : implications for physiology and therapy", Nat Rev Mol Cell Biol, 15, pp.49~63 (2014)
- Sun Y, "2, 5-hexanedione induces human ovarian granulosa cell apoptosis through BCL-2, BAX, and CASPASE-3 signaling pathways", Arch Toxicol, 86, pp.205~215 (2012)
- Roos WP, "DNA damage-induced cell death : from specific DNA lesions to the DNA damage response and apoptosis", Cancer Lett, 332, pp.237~248 (2013)
- Spampanato C, "Simvastatin inhibits cancer cell growth by inducing apoptosis correlated to activation of Bax and down-regulation of BCL-2 gene expression", Int J Oncol, 40, pp.935~941 (2012)
- Hoshyar R, "Crocin triggers the apoptosis through increasing the Bax", Bcl-2 ratio and caspase activation in human gastric adenocarcinoma, AGS, cells, 2013, pp.32, 50~57